- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Vesicular monoamine transporter 2 (VMAT2) inhibitor
Total 104383 results
-
Eli Lilly and CompanyRecruitingType 2 DiabetesTaiwan, United States, China, Mexico, Germany, Poland
-
George Medicines PTY LimitedThe George Institute; Brandon BiocatalystNot yet recruitingType 2 Diabetes
-
Karolinska InstitutetKarolinska University HospitalRecruiting
-
Uppsala UniversityUppsala University Hospital; Swedish Healthcare Regions; Swedish National Board... and other collaboratorsActive, not recruitingType 2 DiabetesSweden
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United States, Mexico, Puerto Rico, Philippines, Russian Federation, Ukraine
-
Chungbuk National University HospitalCompleted
-
Yooyoung Pharmaceutical Co., Ltd.Active, not recruitingType 2 DiabetesKorea, Republic of
-
Getz PharmaCompleted
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; Newcastle University; NHS Tayside; University of Dundee; University... and other collaboratorsCompleted
-
University of MiamiAstraZenecaCompleted
-
MajianhuaCompletedType 2 DiabetesChina
-
LM Diagnósticos S.L.AstraZenecaUnknown
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, India
-
AstraZenecaCompletedType 2 DiabetesKorea, Republic of, Mexico, South Africa, United States, Canada, Puerto Rico, Poland, Romania
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaCompletedType 2 DiabetesUnited States, Puerto Rico, Mexico, Russian Federation, Romania, Poland, Czech Republic, United Kingdom
-
University of Campania "Luigi Vanvitelli"Unknown
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSouth Africa, Germany, Hungary, Romania, Slovakia, Switzerland, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
Taipei Medical University WanFang HospitalUnknown
-
TheracosCompletedDiabetes Mellitus Type 2United States, Canada
-
TheracosCompletedDiabetes Mellitus Type 2United States
-
Universitaire Ziekenhuizen KU LeuvenInstitutul Clinic FundeniCompletedHematological MalignancyBelgium, Romania
-
Number 2 Children's Hospital, Ho Chi Minh CityRecruitingChild Development | Epilepsy; Seizure | Gene Abnormality | Early Onset DisorderVietnam
-
CTI BioPharmaPPDRecruiting
-
Gruppo Oncologico del Nord-OvestBayer; AmgenRecruitingColorectal CancerItaly
-
MenoGeniX, Inc.National Institutes of Health (NIH); National Institute on Aging (NIA)CompletedPostmenopausal SymptomsUnited States
-
American Genomics, LLCCompletedAnesthesia, LocalUnited States
-
University of PadovaCompleted
-
EmitBio Inc.Completed
-
American Genomics, LLCCompletedAnesthesia, LocalUnited States
-
Eisai Inc.Merck Sharp & Dohme LLCCompleted
-
University Hospital, Strasbourg, FranceUnknown
-
Eurocine Vaccines ABCompleted
-
Hopital FochCompletedComplex Regional Pain SyndromeFrance
-
Cumberland PharmaceuticalsCompletedHyponatremiaSouth Africa, United States, Israel
-
Solvay BiologicalsCompleted
-
Akebia TherapeuticsCompletedAnemia | Non-Dialysis-Dependent Chronic Kidney DiseaseUnited States, Italy, Spain, Czechia, Korea, Republic of, Malaysia, Australia, New Zealand, United Kingdom, Germany, Turkey, Ukraine, France, Hungary, Austria, Israel, Bulgaria, Russian Federation, Romania, Slovakia, South Africa, Canad... and more
-
University of MilanNot yet recruiting
-
Boryung Pharmaceutical Co., LtdCompleted
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
University Hospital TuebingenTerminatedType 2 DiabetesGermany
-
Astellas Pharma IncCompleted
-
Mackay Memorial HospitalUnknown
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 DiabetesTaiwan, United States, Argentina, Canada, Mexico, Puerto Rico, Philippines, India, Peru
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Bulgaria, Russian Federation, United Kingdom, Hungary, Romania, Finland, Canada, Austria, Germany, Netherlands, Slovakia, Spain
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCzech Republic, Korea, Republic of, Hungary, Poland, Ukraine, Philippines, Thailand